Brinter Bio-Implant company joined the RegeneratOR’s Innovation Accelerator in 2023, located in the Regenerative Medicine Hub (RegenMed Hub), a rapidly growing regenerative medicine ecosystem based in the Innovation Quarter, in Winston-Salem.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Joann B. Sweasy, PhD, has been elected to serve as vice president/president-elect of AACI’s Board of Directors. Three new board members were also chosen: Edward Chu, MD, MMS; Raymond N. DuBois, MD, PhD; and Yolanda Sanchez, PhD.
No mundo todo, o papilomavírus humano (HPV) é responsável por grande parte dos cânceres de cabeça e pescoço, de acordo com a Organização Mundial da Saúde.
It’s a beautiful moniker, but for the world's butterfly children’ it belies a devastating reality filled with enormous pain and suffering caused by a rare skin condition – Epidermolysis Bullosa (EB).
University of Illinois scientists have identified a protein that plays a critical role in the action of several emerging cancer therapies. The discovery will likely aid efforts to fine-tune the use of immunotherapies against several challenging cancers.
Pilot awards, pre-doctoral fellowship awards and post-doctoral awards totaling $1.5 million were recently awarded to Rutgers Cancer Institute of New Jersey investigators by the New Jersey Commission on Cancer Research (NJCCR).
Niki Patel, MD, a fellowship-trained hematologist-oncologist board certified in internal medicine and medical oncology, has joined the Division of Medical Oncology at Cedars-Sinai Cancer. She is treating patients in Pasadena at Huntington Cancer Center at Huntington Health, an affiliate of Cedars-Sinai.
Susan G. Komen®, the world’s leading breast cancer organization, announced the fourth MBC-focused research grant supported through the Komen Metastatic Breast Cancer Collaborative Research Initiative (MBCCRI), a collaboration between Komen, Duke Cancer Institute and the University of North Carolina Lineberger Comprehensive Cancer Center, which pairs researchers from each of the organizations to work together and address significant gaps in our knowledge about MBC to advance patient care and improve patient outcomes.
UC San Diego Health is among the first in the nation to perform an experimental regenerative brain cell therapy for epilepsy aimed at eliminating seizures.
UT Southwestern Medical Center biologists have developed a new stem cell-based embryo model for studying early human development, tissue formation, and differentiation, offering valuable contributions to the field of developmental biology and regenerative medicine.
In the next step toward producing the answer to kidney transplantation shortages, Dr. Anthony Atala, Director of the Wake Forest Institute for Regenerative Medicine (WFIRM), and the kidney research team, have been awarded the prestigious KidneyX Track 2 $1 Million Prize for work based on a 3D kidney construct platform.
Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea.
Hematopoietic stem cells (HSCs) are rare cells found in the bone marrow that produce red blood cells, white blood cells, and platelets.
In situ bioprinting, which involves 3D printing biocompatible structures and tissues directly within the body, has seen steady progress over the past few years.
Cedars-Sinai investigators studying the effects of space on stem cells will present their work at the International Society for Stem Cell Research (ISSCR) Annual Meeting June 14-17 in Boston, and are available for interviews throughout the conference.
In this project volumetric bioprinting was for the first time successfully combined with melt electrowriting.
Ongoing research at UT Southwestern Medical Center exploring the ability of human heart cells to regenerate after a heart attack or other cardiovascular event will be accelerated by a new award from the National Institutes of Health.
The early stages of embryonic development contain many of life’s mysteries. Unlocking these mysteries can help us better understand early development and birth defects, and help develop new regenerative medicine treatments.
Tissue engineering research has shown that a skin cell type could be a new therapeutic target to accelerate the healing of burns and possibly other wounds.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
